Monatepil

This classification denotes a calcium channel blocker with the molecular formula C28H30FN3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, N4MMI0J7PW chemically known as 1-piperazinebutanamide, n-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl) but generally known as monatepil, which bears US NIH Compound Identifier 5282401. European Medicines Agency schedules Monatepil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09047MIG. The term MONATEPIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33). Most nations schedule monatepil under HS 29349990 and SITC 51579. As of Q4 2014, MONATEPIL remains the US FDA Preferred Term for this commodity. Monatepil bears US NLM identifiers UMLS ID CL412665 and NCI Concept Code C83970. SMILES: C1CN(CCN1CCCC(=O)NC2C3=CC=CC=C3CSC4=CC=CC=C24)C5=CC=C(C=C5)F.C(=C\C(=O)O)\C(=O)O.